Moody’s affirms Centra Health’s ‘A2’ rating

Moody’s Investors Service has affirmed Lynchburg, Va.-based Centra Health’s “A2” rating, affecting $150.3 million of outstanding debt.

Advertisement

The rating affirmation is based on a number of factors, including Centra’s leading market position, growth in size and scope of operations and healthy wealth levels. Centra Health also faces several challenges, including its expanding expense based.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Centra will maintain operating and cash flow margins at current levels.

More articles on healthcare finance:
Medac, AnesthesiaOSTM form billing partnership
US spends $15.5B annually on disease-associated malnutrition
TransUnion acquires software firm, SwervePay adds new executive & more— 8 RCM keynotes

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.